Skip Navigation


Rheumatology Advance Access originally published online on June 6, 2007
Rheumatology 2007 46(8):1379; doi:10.1093/rheumatology/kem038
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
46/8/1379    most recent
kem038v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Huggett, M. T.
Right arrow Articles by Armstrong, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huggett, M. T.
Right arrow Articles by Armstrong, R.
Related Collections
Right arrow Rheumatoid Arthritis
Right arrow Rehabilitation
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Adalimumab-associated pulmonary fibrosis – reply

M. T. Huggett and R. Armstrong

Department of Rheumatology, Southampton University Hospitals NHS Trust, UK

Correspondence to: M. Huggett. E-mail: matthewhuggett@doctors.net.uk

The first 10% of the full text of this article appears below.

SIR, We thought that the response to our case report (by Collins et al.) about a patient with adalimumab-associated pulmonary fibrosis . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?